Navidea Biopharmaceuticals Stock Price - NAVB


-1.07 (-100.00%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Navidea Biopharmaceuticals Inc NAVB AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 1.07 0.00 0.00 0.00 1.07 04:00:00
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Navidea Biopharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 19.34M 18.08M $ -16.11M -1.80 - 38.96k
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
525.25k $ - 0.00% 1.00 99.80%

more financials information »

Navidea Biopharmaceuticals News

Loading Messages....

Latest NAVB Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NAVB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.001.300.951.13291,9050.077.0%
1 Month1.431.470.951.17159,875-0.36-25.17%
3 Months0.79751.810.76531.18169,1940.272534.17%
6 Months0.511.810.50041.07358,3770.56109.8%
1 Year0.193.000.1220.740334402,3190.88463.16%
3 Years0.453.000.10010.4816081431,2840.62137.78%
5 Years1.663.000.10010.8407065612,818-0.59-35.54%

Navidea Biopharmaceuticals Description

Navidea Biopharmaceuticals Inc is a biotechnology company specialized in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products, are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.


Your Recent History
AMEX
NAVB
Navidea Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.